Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vaou EO"'
Autor:
Soileau MJ; Texas Movement Disorder Specialists, Georgetown, TX, USA. Electronic address: msoileau@txmds.net., Aldred J; Selkirk Neurology & Inland Northwest Research, Spokane, WA, USA., Budur K; AbbVie, North Chicago, IL, USA., Fisseha N; AbbVie, North Chicago, IL, USA., Fung VS; Movement Disorders Unit, Westmead Hospital, Westmead, Australia; Sydney Medical School, University of Sydney, Sydney NSW, Australia., Jeong A; AbbVie, North Chicago, IL, USA., Kimber TE; Royal Adelaide Hospital, Adelaide, SA, Australia; Department of Medicine, University of Adelaide, Adelaide, SA, Australia., Klos K; Movement Disorder Clinic of Oklahoma, Tulsa, OK, USA., Litvan I; Parkinson and Other Movement Disorders Center, University of California San Diego, La Jolla, CA, USA., O'Neill D; South Western Sydney Local Health District, Liverpool, NSW, Australia., Robieson WZ; AbbVie, North Chicago, IL, USA., Spindler MA; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Standaert DG; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA., Talapala S; AbbVie, North Chicago, IL, USA., Vaou EO; Steward St Elizabeth's Medical Center, Brighton, MA, USA., Zheng H; AbbVie, North Chicago, IL, USA., Facheris MF; AbbVie, North Chicago, IL, USA., Hauser RA; University of South Florida Parkinson's Disease and Movement Disorders Center of Excellence, Tampa, FL, USA.
Publikováno v:
The Lancet. Neurology [Lancet Neurol] 2022 Dec; Vol. 21 (12), pp. 1099-1109.